1-20 of 47
Tanya M Wildes, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Single Center Retrospective Analysis of Daratumumab, Pomalidomide, and Dexamethasone As a Second Line Therapy for Multiple Myeloma

Lawrence Liu, MD, Gao Feng, MD PhD MPH, Mark A. Fiala, MSW, Justin King, BS, Scott R. Goldsmith, MD, Tanya M. Wildes, MD MSCI, Keith E. Stockerl-Goldstein, MD, Ravi Vij, MBBS, Mark A. Schroeder, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 31–32.
https://doi.org/10.1182/blood-2020-137023
Published: 2020
Journal Articles

A Preliminary Assessment of Heterozygous CFHR3-CFHR1 Deletion As a Permissive Mutation in Carfilzomib-Induced Atypical Hemolytic Uremic Syndrome

Andrew Jay Portuguese, MD, Mark A Fiala, MSW, Tanya M. Wildes, MD MSCI, Ravi Vij, MBBS, Brea Lipe, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 8–9.
https://doi.org/10.1182/blood-2020-134154
Published: 2020
Journal Articles

Daratumumab (DARA) Plus Lenalidomide, Bortezomib, and Dexamethasone (RVd) in Patients with Transplant-Eligible Newly Diagnosed Multiple Myeloma (NDMM): Updated Analysis of Griffin after 12 Months of Maintenance Therapy

Jonathan L. Kaufman, MD, Jacob P. Laubach, Douglas Sborov, MD MS, Brandi Reeves, MD, Cesar Rodriguez, MD, Ajai Chari, Rebecca W. Silbermann, MD, Luciano J. Costa, MD PhD, Larry D. Anderson, Jr., MD PhD, Nitya Nathwani, MD, Nina Shah, MD, Yvonne A. Efebera, MD MPH, Sara A. Holstein, MDPhD, Caitlin Costello, Andrzej Jakubowiak, MD PhD, Tanya M. Wildes, MD MSCI, Robert Z. Orlowski, MDPhD, Kenneth H. Shain, MD PhD, Andrew J. Cowan, Yana Lutska, PharmD, Padma Bobba, Huiling Pei, PhD, Jon Ukropec, PhD, Jessica Vermeulen, MD PhD, Thomas S. Lin, MD PhD, Paul G. Richardson, MD, Peter M. Voorhees
Journal: Blood
Blood (2020) 136 (Supplement 1): 45–46.
https://doi.org/10.1182/blood-2020-137109
Published: 2020
Journal Articles

Decision Making Factors That Influence Treatment Options for an Autologous Stem Cell Transplant for Older Adults (aged 65-75) with Newly Diagnosed Multiple Myeloma: A Mixed Methods Study

Owais Mian, BHSc, Martine Puts, PhD RN, Arleigh McCurdy, MD BSc, Tanya M. Wildes, MD MSCI, Mark A Fiala, MSW, Matthew Kang, MDFRCPC, Mary Salib, MD, Shabbir Alibhai, MD MSc, Hira S Mian, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 13.
https://doi.org/10.1182/blood-2020-139008
Published: 2020
Journal Articles

Patient and Disease Factors Predict Risk of 1-Year Mortality Among Older Adults Who Receive Intensive Chemotherapy for Hodgkin Lymphoma (HL)

Anita J Kumar, MDMS, Jason Nelson, MPH, Angie Mae Rodday, PhD, Andrew M. Evens, DO,MMSc, Jonathan W. Friedberg, MD MSSc, Tanya M. Wildes, MD MSCI, Susan K Parsons, MD MRP
Journal: Blood
Blood (2020) 136 (Supplement 1): 6–7.
https://doi.org/10.1182/blood-2020-140823
Published: 2020
Journal Articles

Trajectory of Symptoms after Autologous Stem Cell Transplant Among Patients with Multiple Myeloma: A Population-Based Study

Hira S Mian, MD, Gregory R Pond, PhD PStat, Tanya M. Wildes, MD MSCI, Branavan Sivapathasundaram, MSc, Jonathan Sussman, MD FRCPC, MSc, Hsien Seow, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 1–2.
https://doi.org/10.1182/blood-2020-133869
Published: 2020
Journal Articles

Symptom Burden in Transplant Ineligible Patients with Newly Diagnosed Multiple Myeloma: A Population-Based Study of Patient-Reported Outcomes

Hira S Mian, MD, Gregory R Pond, PhD PStat, Branavan Sivapathasundaram, MSc, Tanya M. Wildes, MD MSCI, Jonathan Sussman, MD FRCPC, MSc, Hsien Seow, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 30–31.
https://doi.org/10.1182/blood-2020-133369
Published: 2020
Journal Articles

Depth of Response to Daratumumab (DARA), Lenalidomide, Bortezomib, and Dexamethasone (RVd) Improves over Time in Patients (pts) with Transplant-Eligible Newly Diagnosed Multiple Myeloma (NDMM): Griffin Study Update

Peter M. Voorhees, MD, Jonathan L. Kaufman, MD, Jacob P. Laubach, MD, Douglas W. Sborov, MD MSc, Brandi Reeves, MD, Cesar Rodriguez, MD, Ajai Chari, MD, Rebecca W. Silbermann, MD, Luciano J. Costa, MD PhD, Larry D. Anderson, MD PhD, Nitya Nathwani, MD, Nina D. Shah, MD, Yvonne A. Efebera, MD MPH, Caitlin L. Costello, MD, Andrzej Jakubowiak, MD PhD, Tanya M. Wildes, MD, Robert Z. Orlowski, MD PhD, Kenneth H. Shain, MD PhD, Andrew J. Cowan, MD, Sean Murphy, Yana Lutska, PharmD, Huiling Pei, PhD, Jon Ukropec, PhD, Jessica Vermeulen, MD PhD, Carla de Boer, Daniela Hoehn, MD PhD, Thomas S. Lin, MD PhD, Paul G. Richardson, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 691.
https://doi.org/10.1182/blood-2019-123465
Published: 2019
Journal Articles

The Ire of IRE1α: Overexpression of IRE1α at Myeloma Diagnosis Is Associated with Decreased Survival While Downregulation of IRE1α Expression Is Predictive of Therapy Resistance

Scott R. Goldsmith, MD, Mark A. Fiala, BS, Mark A. Schroeder, MD, Tanya M. Wildes, MD, Armin Ghobadi, MD, Ravi Vij, MBBS, Keith E. Stockerl-Goldstein, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4351.
https://doi.org/10.1182/blood-2019-131135
Published: 2019
Journal Articles

Analysis of Falls in Older Adults with Multiple Myeloma Undergoing First-Line Therapy

Kelly L. Schoenbeck, MD, Tanya M. Wildes, MD, Mark A. Fiala, BS
Journal: Blood
Blood (2019) 134 (Supplement_1): 5886.
https://doi.org/10.1182/blood-2019-129611
Published: 2019
Journal Articles

Characterizing Inclusion and Exclusion Criteria in Clinical Trials for CAR-T Cellular Therapy Among Adults with Hematologic Malignancies

Jordon Jaggers, Heidi D. Klepin, MD, Tanya M. Wildes, MD, Rebecca L. Olin, MD, Andrew S. Artz, MD, Sarah A Wall, MD, Samantha Jaglowski, MDMPH, Basem M. William, MRCP,MD, Don M. Benson, Jr., MD PhD, Ashley E. Rosko, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5819.
https://doi.org/10.1182/blood-2019-131504
Published: 2019
Journal Articles

Integrating Touchscreen-Based Geriatric Assessment and Frailty Screening for Adults with Multiple Myeloma to Drive Personalized Treatment Decisions

Nitya Nathwani, MD, Supriya G. Mohile, MD MS, Sandra Kurtin, PhD, ANP-C, AOCN, Debra Wujcik, PhD, Susie Owenby, Matthew Dudley, William Dudley, PhD, Tanya M. Wildes, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3443.
https://doi.org/10.1182/blood-2019-130245
Published: 2019
Journal Articles

Frailty in Older Adults with Multiple Myeloma: A Study of United States Veterans

Bindiya Patel, MD, Suhong Luo, MPH, Tanya M. Wildes, MD, Kristen M. Sanfilippo, MD MPHS
Journal: Blood
Blood (2019) 134 (Supplement_1): 3478.
https://doi.org/10.1182/blood-2019-124971
Published: 2019
Journal Articles

Utilization of Autologous Stem Cell Transplantation in Older Patients with Newly Diagnosed Multiple Myeloma

Justin King, Mark A. Fiala, BS, Scott R. Goldsmith, MD, Keith E. Stockerl-Goldstein, MD, Mark A. Schroeder, MD, Armin Ghobadi, MD, Ravi Vij, MBBS, Tanya M. Wildes, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5701.
https://doi.org/10.1182/blood-2019-130689
Published: 2019
Journal Articles

Geriatric Assessment and Frailty Changes in Older Patients with Newly-Diagnosed Multiple Myeloma Undergoing Treatment

Hira S Mian, MD, Gregory R Pond, PhD PStat, Sascha A Tuchman, MD, Mark A. Fiala, BS, Tanya M. Wildes, MD MSCI
Journal: Blood
Blood (2019) 134 (Supplement_1): 4774.
https://doi.org/10.1182/blood-2019-122261
Published: 2019
Journal Articles

The Characteristics, Treatment Patterns, and Outcomes of Older Adults with Multiple Myeloma

Mark A. Fiala, BS, Tanya M. Wildes, MD MSCI, Mark A. Schroeder, MD, Armin Ghobadi, MD, Keith E. Stockerl-Goldstein, MD, Ravi Vij, MBBS
Journal: Blood
Blood (2018) 132 (Supplement 1): 4463.
https://doi.org/10.1182/blood-2018-99-118660
Published: 2018
Journal Articles

Limitations to Receiving Allogeneic Hematopoietic Cell Transplantation for Treatment of Acute Myeloid Leukemia: A Large Multi-Center Prospective Longitudinal Observational Study

Mohamed L. Sorror, MD MSc, Barry E. Storer, PhD, Aaron T. Gerds, MDMS, Bruno C. Medeiros, MD, Paul J Shami, MD, John P. Galvin, MDMS,MPH, Kehinde U. Adekola, MBBS,MS, Selina Luger, MD, Maria R. Baer, MD, David A. Rizzieri, MD, Tanya M. Wildes, MD MSCI, Eunice S. Wang, MD, Stefan Faderl, MD, Jamie L. Koprivnikar, MD, Mikkael A. Sekeres, MD MS, Sudipto Mukherjee, MDPhDMPH, Julie Smith, MD, Mitchell Garrison, MD, Kiarash Kojouri, MD, Jennifer E. Nyland, PhD, Rachelle R. Moore, BS, Sophie L. Fleuret, BS, Ylinne Lynch, MD, Pamela S. Becker, MD, Mary-Elizabeth M. Percival, MD, Brenda M. Sandmaier, MD, Frederick R. Appelbaum, MD, Elihu H. Estey, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1388.
https://doi.org/10.1182/blood-2018-99-112672
Published: 2018
Journal Articles

Increasing Daratumumab Frequency As a Way to Restore Responses- a Retrospective Case Study

Angela Vickroy, ANP, Adam Kent Peery, BS,ANP, Mark A. Fiala, BS, Tanya M. Wildes, MD MSCI, Mark A. Schroeder, MD, Armin Ghobadi, MD, Keith E. Stockerl-Goldstein, MD, Ravi Vij, MBBS
Journal: Blood
Blood (2018) 132 (Supplement 1): 5666.
https://doi.org/10.1182/blood-2018-99-119589
Published: 2018
Journal Articles

Bendamustine in Patients with Quad- and Penta-Refractory Multiple Myeloma

Scott Goldsmith, MD, Mark A. Fiala, BS, Brandon B. Wang, Mark A. Schroeder, MD, Tanya M. Wildes, MD MSCI, Armin Ghobadi, MD, Keith E. Stockerl-Goldstein, MD, Ravi Vij, MBBS
Journal: Blood
Blood (2018) 132 (Supplement 1): 5627.
https://doi.org/10.1182/blood-2018-99-112258
Published: 2018
Journal Articles

Disparities in Healthcare Resource Utilization for Multiple Myeloma

Mark A. Fiala, BS, Tanya M. Wildes, MD MSCI, Mark A. Schroeder, MD, Armin Ghobadi, MD, Keith E. Stockerl-Goldstein, MD, Ravi Vij, MBBS
Journal: Blood
Blood (2018) 132 (Supplement 1): 4793.
https://doi.org/10.1182/blood-2018-99-118392
Published: 2018